Larry Wood Biography and Net Worth

Larry L. Wood has been corporate vice president, Transcatheter Aortic Valve Replacement, since 2007, and has been responsible for key company R&D, operations, marketing, commercial, clinical and regulatory initiatives in transcatheter valve replacement around the globe since the program was a development project. Under his leadership, the Edwards SAPIEN heart valve has won numerous awards, including the Prix Galien “Best Medical Technology Product” award and was named Popular Science’s “Best of What’s New” Grand Award winner in the Health category. Wood has more than 25 years of experience in the medical device industry at both Edwards and Baxter International, and is a frequently invited faculty member at key interventional cardiology and cardiothoracic surgery scientific congresses. Wood previously held key positions in manufacturing management, regulatory affairs, and strategic and clinical marketing, primarily in the company’s leading surgical heart valve franchise. Wood received his master’s degree in business administration from Pepperdine University.

What is Larry L. Wood's net worth?: The estimated net worth of Larry L. Wood is at least $14.07 million as of November 5th, 2024. Mr. Wood owns 198,526 shares of Edwards Lifesciences stock worth more than $14,074,699 as of March 29th. This net worth estimate does not reflect any other assets that Mr. Wood may own. Additionally, Mr. Wood receives an annual salary of $1,490,000.00 as VP at Edwards Lifesciences. Learn More about Larry L. Wood's net worth.
How old is Larry L. Wood?: Mr. Wood is currently 58 years old. There are 6 older executives and no younger executives at Edwards Lifesciences. The oldest executive at Edwards Lifesciences is Mr. Arnold A. Pinkston, Corporate VP & General Counsel, who is 65 years old. Learn More on Larry L. Wood's age.
What is Larry L. Wood's salary?: As the VP of Edwards Lifesciences Co., Mr. Wood earns $1,490,000.00 per year. The highest earning executive at Edwards Lifesciences is Mr. Bernard J. Zovighian, CEO & Director, who commands a salary of $2,270,000.00 per year. Learn More on Larry L. Wood's salary.
How do I contact Larry L. Wood?: The corporate mailing address for Mr. Wood and other Edwards Lifesciences executives is ONE EDWARDS WAY, IRVINE CA, 92614. Edwards Lifesciences can also be reached via phone at (949) 250-2500 and via email at investor_relations@edwards.com. Learn More on Larry L. Wood's contact information.
Has Larry L. Wood been buying or selling shares of Edwards Lifesciences?: Larry L. Wood has not been actively trading shares of Edwards Lifesciences over the course of the past ninety days. Most recently, Larry L. Wood sold 25,000 shares of the business's stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $65.91, for a transaction totalling $1,647,750.00. Following the completion of the sale, the insider now directly owns 198,526 shares of the company's stock, valued at $13,084,848.66. Learn More on Larry L. Wood's trading history.
Who are Edwards Lifesciences' active insiders?: Edwards Lifesciences' insider roster includes Donald Bobo, Jr (VP), Daveen Chopra (VP), Kieran Gallahue (Director), Leslie Heisz (Director), Jean-Luc Lemercier (VP), Daniel Lippis (VP), Martha Marsh (Director), Michael Mussallem (CEO), Robert Sellers (VP), Catherine Szyman (VP), Scott Ullem (CFO), Nicholas Valeriani (Director), Huimin Wang (VP), Larry Wood (VP), and Bernard Zovighian (VP). Learn More on Edwards Lifesciences' active insiders.
Are insiders buying or selling shares of Edwards Lifesciences?: In the last year, Edwards Lifesciences insiders bought shares 1 times. They purchased a total of 580 shares worth more than $49,729.20. In the last year, insiders at the medical research company sold shares 28 times. They sold a total of 243,407 shares worth more than $19,507,015.48. The most recent insider tranaction occured on March, 26th when CFO Scott B Ullem sold 11,250 shares worth more than $797,287.50. Insiders at Edwards Lifesciences own 1.3% of the company. Learn More about insider trades at Edwards Lifesciences.
Information on this page was last updated on 3/26/2025.

Larry L. Wood Insider Trading History at Edwards Lifesciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/5/2024	Sell	25,000	$65.91	$1,647,750.00	198,526
12/13/2023	Sell	8,658	$71.86	$622,163.88	213,794
11/13/2023	Sell	8,660	$65.30	$565,498.00	213,794
10/13/2023	Sell	8,660	$70.00	$606,200.00	213,794
9/14/2023	Sell	8,660	$73.63	$637,635.80	213,794
8/14/2023	Sell	6,421	$79.30	$509,185.30	213,794
7/14/2023	Sell	8,660	$92.94	$804,860.40	213,794
6/14/2023	Sell	8,660	$90.15	$780,699.00	213,794
5/24/2023	Sell	6,421	$84.23	$540,840.83	213,794
7/5/2022	Sell	7,242	$95.90	$694,507.80	202,232
5/10/2022	Sell	7,242	$96.13	$696,173.46	206,069
4/5/2022	Sell	7,242	$121.03	$876,499.26	197,641
2/8/2022	Sell	4,386	$109.55	$480,486.30
12/10/2021	Sell	7,830	$121.49	$951,266.70
11/10/2021	Sell	7,830	$119.79	$937,955.70
10/11/2021	Sell	7,830	$108.00	$845,640.00
7/12/2021	Sell	7,830	$107.48	$841,568.40	379,964
6/14/2021	Sell	7,830	$99.91	$782,295.30	379,902
5/10/2021	Sell	7,830	$92.22	$722,082.60	367,679
4/12/2021	Sell	7,830	$85.84	$672,127.20	371,613
3/1/2021	Sell	7,830	$83.99	$657,641.70	371,313
11/2/2020	Sell	10,698	$73.27	$783,842.46	374,181
10/1/2020	Sell	10,698	$80.38	$859,905.24	374,181
9/1/2020	Sell	10,698	$85.09	$910,292.82	374,181
8/3/2020	Sell	10,698	$78.40	$838,723.20	374,181
7/1/2020	Sell	10,698	$68.90	$737,092.20	374,181
6/1/2020	Sell	10,698	$75.30	$805,559.40	374,097
5/1/2020	Sell	3,566	$215.00	$766,690.00	121,102
4/1/2020	Sell	3,566	$180.84	$644,875.44	121,102
3/2/2020	Sell	3,566	$207.00	$738,162.00	120,995
2/3/2020	Sell	3,566	$219.50	$782,737.00	120,995
1/2/2020	Sell	8,568	$229.98	$1,970,468.64	122,431
11/1/2019	Sell	6,716	$239.75	$1,610,161.00	124,145
10/1/2019	Sell	6,716	$218.24	$1,465,699.84	124,145
9/3/2019	Sell	6,716	$219.91	$1,476,915.56	124,145
8/1/2019	Sell	6,716	$213.31	$1,432,589.96	124,145
7/1/2019	Sell	6,716	$186.95	$1,255,556.20	124,145
6/3/2019	Sell	6,716	$169.75	$1,140,041.00	124,102
5/1/2019	Sell	6,716	$176.34	$1,184,299.44	122,495
4/1/2019	Sell	6,716	$192.34	$1,291,755.44	122,495
3/1/2019	Sell	6,716	$170.82	$1,147,227.12	122,366
2/4/2019	Sell	6,716	$169.10	$1,135,675.60	35,224
1/7/2019	Sell	6,716	$148.15	$994,975.40	122,366
12/14/2018	Sell	6,300	$162.66	$1,024,758.00	27,028
11/15/2018	Sell	6,300	$147.96	$932,148.00	25,490
9/14/2018	Sell	6,300	$146.95	$925,785.00	121,950
7/16/2018	Sell	6,300	$148.02	$932,526.00	121,950
6/15/2018	Sell	6,300	$151.86	$956,718.00
5/15/2018	Sell	6,300	$137.26	$864,738.00
4/16/2018	Sell	6,300	$138.97	$875,511.00
3/15/2018	Sell	6,300	$141.49	$891,387.00	116,148
2/16/2018	Sell	6,300	$134.27	$845,901.00	116,148
1/16/2018	Sell	6,300	$121.00	$762,300.00	116,148
12/15/2017	Sell	18,960	$114.58	$2,172,436.80
11/15/2017	Sell	18,960	$104.76	$1,986,249.60
10/16/2017	Sell	18,960	$108.54	$2,057,918.40
9/15/2017	Sell	18,960	$112.58	$2,134,516.80
8/30/2017	Sell	18,960	$111.81	$2,119,917.60
12/1/2016	Sell	13,258	$81.85	$1,085,167.30
11/1/2016	Sell	13,257	$93.27	$1,236,480.39
10/3/2016	Sell	13,257	$119.27	$1,581,162.39
8/1/2016	Sell	13,257	$114.24	$1,514,479.68
7/1/2016	Sell	13,257	$98.79	$1,309,659.03
6/3/2016	Sell	13,257	$101.38	$1,343,994.66	115,083
10/1/2015	Sell	7,680	$141.52	$1,086,873.60	43,838
9/1/2015	Sell	7,680	$137.50	$1,056,000.00	43,838
7/1/2015	Sell	7,680	$143.51	$1,102,156.80
6/1/2015	Sell	7,680	$130.47	$1,002,009.60
5/1/2015	Sell	7,680	$127.12	$976,281.60
4/1/2015	Sell	7,680	$142.06	$1,091,020.80
3/2/2015	Sell	7,680	$132.62	$1,018,521.60
8/18/2014	Sell	63,752	$97.85	$6,238,133.20

See Full Table

Larry L. Wood Buying and Selling Activity at Edwards Lifesciences

Edwards Lifesciences Company Overview

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Today's Range

Now: $70.90

$70.63

$71.66

50 Day Range

MA: $71.49

$67.92

$76.23

2 Week Range

Now: $70.90

$58.93

$95.73

Volume

4,513,774 shs

Average Volume

4,808,659 shs

Market Capitalization

$41.68 billion

P/E Ratio

10.17

Dividend Yield

N/A

Beta

1.12

Larry Wood Biography and Net Worth

What is Larry L. Wood's net worth?

How old is Larry L. Wood?

What is Larry L. Wood's salary?

How do I contact Larry L. Wood?

Has Larry L. Wood been buying or selling shares of Edwards Lifesciences?

Who are Edwards Lifesciences' active insiders?

Are insiders buying or selling shares of Edwards Lifesciences?